EUVIMEDEUVIMED entdecken
Crossref

TNFR2 signaling promotes monocytic‐ MDSC differentiation and production of immunosuppressive mediators

Yuta Tsuji, Masaki Inoue, Tomoya Okuda, Momona Murata, Shogo Imagaki, Nanami Taniyama, Honoka Yoshikawa, Hanae Kuroiwa, Shin-Ichi Tsunoda iD

FEBS Letters · 2026

DOI: 10.1002/1873-3468.70314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, 2026. Verfasst von Yuta Tsuji und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Faculty of Pharmaceutical Sciences, Laboratory of Cellular and Molecular Physiology, Kobe Gakuin University, Japan. Hauptthemen laut MEDLINE: Cell Differentiation, Receptors, Tumor Necrosis Factor, Type II, Signal Transduction, Myeloid-Derived Suppressor Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Hyogo Science and Technology Association Academic Research Grant, Hyogo Science and Technology Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid‐derived suppressor cells (MDSCs) differentiate and proliferate in the pathological context of cancer, suppress T‐cell responses, and promote tumor progression and therapeutic resistance. These cells express high levels of TNF receptor type 2 (TNFR2), but the ligand TNF‐α also activates TNFR1, masking TNFR2‐specific function. We analyzed TNFR2 signaling using GM‐CSF‐induced MDSCs from TNFR2‐knockout mice and scR2agoTNF‐Fc, a TNFR2‐selective agonist. Stimulation with scR2agoTNF‐Fc maintained a highly suppressive monocytic subset. TNFR2 deficiency reduced MDSC‐mediated T‐cell suppression. TNFR2 activation also increased the expression of immunosuppressive effector molecules such as inducible nitric‐oxide synthase and interleukin‐10. These results indicate that TNFR2 is a promising therapeutic target for modulating the differentiation and immunosuppressive functions of MDSC subsets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell DifferentiationReceptors, Tumor Necrosis Factor, Type IISignal TransductionMyeloid-Derived Suppressor CellsMonocytesImmunosuppressive AgentsAnimalsMiceInterleukin-10Mice, KnockoutNitric Oxide Synthase Type IITumor Necrosis Factor-alphaGranulocyte-Macrophage Colony-Stimulating FactorT-LymphocytesMice, Inbred C57BL

Stichwörter der Autor:innen

IL‐10ImmunosuppressionMDSCTNFR2TNF‐αiNOS

Substanzen

Receptors, Tumor Necrosis Factor, Type IIInterleukin-10Nitric Oxide Synthase Type IITumor Necrosis Factor-alphaTnfrsf1b protein, mouseGranulocyte-Macrophage Colony-Stimulating FactorImmunosuppressive Agents

Autor:innen und Institutionen

  • The Faculty of Pharmaceutical Sciences, Laboratory of Cellular and Molecular Physiology, Kobe Gakuin University, Japan.

ORCID-Profile: Shin-Ichi Tsunoda

Förderung

  • Japan Society for the Promotion of Science
  • Hyogo Science and Technology Association Academic Research Grant
  • Hyogo Science and Technology Association

Zitieren

APA

Tsuji, Y., Inoue, M., Okuda, T., Murata, M., Imagaki, S., Taniyama, N., Yoshikawa, H., Kuroiwa, H., & Tsunoda, S. I. (2026). TNFR2 signaling promotes monocytic‐ MDSC differentiation and production of immunosuppressive mediators. FEBS Letters. https://doi.org/10.1002/1873-3468.70314

Vancouver

Tsuji Y, Inoue M, Okuda T, Murata M, Imagaki S, Taniyama N, et al. TNFR2 signaling promotes monocytic‐ MDSC differentiation and production of immunosuppressive mediators. FEBS Letters. 2026. doi:10.1002/1873-3468.70314

BibTeX
@article{Tsuji2026,
  author = {Tsuji, Yuta and Inoue, Masaki and Okuda, Tomoya and Murata, Momona and Imagaki, Shogo and Taniyama, Nanami and Yoshikawa, Honoka and Kuroiwa, Hanae and Tsunoda, Shin-Ichi},
  title = {TNFR2 signaling promotes monocytic‐ MDSC differentiation and production of immunosuppressive mediators},
  journal = {FEBS Letters},
  year = {2026},
  doi = {10.1002/1873-3468.70314}
}
Kostenlos starten →